Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology

被引：0
|
作者：
Guilherme Povala
Bruna Bellaver
Marco Antônio De Bastiani
Wagner S. Brum
Pamela C. L. Ferreira
Andrei Bieger
Tharick A. Pascoal
Andrea L. Benedet
Diogo O. Souza
Ricardo M. Araujo
Bruno Zatt
Pedro Rosa-Neto
Eduardo R. Zimmer
机构：
[1] Universidade Federal do Rio Grande do Sul (UFRGS),Graduate Program in Biological Sciences: Biochemistry
[2] Universidade Federal de Pelotas (UFPEL),Graduate Program in Computing
[3] University of Pittsburgh,Department of Neurology and Psychiatry
[4] The McGill University Research Centre for Studies in Aging,Translational Neuroimaging Laboratory
[5] Montreal Neurological Institute,Department of Biochemistry
[6] Universidade Federal do Rio Grande do Sul (UFRGS),Douglas Hospital
[7] McGill University,Department of Pharmacology
[8] Universidade Federal do Rio Grande do Sul (UFRGS),Graduate Program in Biological Sciences: Pharmacology and Therapeutics
[9] Universidade Federal do Rio Grande do Sul (UFRGS),undefined
来源：
Cell & Bioscience | / 11卷
关键词：
Alzheimer’s disease; Amyloid-beta; Tau pathology; Neurodegeneration; Machine learning; Proteomics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Impaired hepatic amyloid-beta degradation in Alzheimer's disease
    Maarouf, Chera L.
    Walker, Jessica E.
    Sue, Lucia I.
    Dugger, Brittany N.
    Beach, Thomas G.
    Serrano, Geidy E.
    PLOS ONE, 2018, 13 (09):
  • [32] Plasma amyloid-beta and serum amyloid-beta auto-antibody levels in patients with Alzheimer's disease
    Zhou, L.
    Chu, L. W.
    Kwan, J. S. C.
    Lam, K. S. L.
    Cheng, O. Y.
    Chan, K. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 98 - 98
  • [33] Amyloid-beta immunotherapy: the hope for Alzheimer disease?
    Barrera-Ocampo, Alvaro
    Lopera, Francisco
    COLOMBIA MEDICA, 2016, 47 (04): : 203 - 212
  • [34] Imaging of Amyloid-Beta Deposits in the Postmortem Retina in Alzheimer's Disease
    Campbell, M. C. W.
    Gowing, L. J. F.
    Choi, Y.
    Leonenko, Z.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [35] Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives
    Wang, Yan-Jiang
    Zhou, Hua-Dong
    Zhou, Xin-Fu
    DRUG DISCOVERY TODAY, 2006, 11 (19-20) : 931 - 938
  • [36] Failure of elimination of amyloid-beta from the brain in Alzheimer's disease
    de Silva, Prasanna
    Carare, Roxana O.
    Weller, Roy O.
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2008, 12 (04) : 6 - 10
  • [37] Plasma Amyloid-Beta Levels in Korean Patients with Alzheimer's Disease
    Cho, Sun Young
    Kang, So Young
    Lee, Woo In
    CLINICAL LABORATORY, 2016, 62 (08) : 1591 - 1593
  • [38] Amyloid-beta protein related treatment strategies in Alzheimer's disease
    Dodel, R
    EUROPEAN PSYCHIATRY, 2004, 19 : 102S - 102S
  • [39] Clusterin in Alzheimer’s disease: a player in the biological behavior of amyloid-beta
    Xiang Li
    Yifei Ma
    Xu Wei
    Yanpeng Li
    Huijuan Wu
    Jianhua Zhuang
    Zhongxin Zhao
    Neuroscience Bulletin, 2014, 30 : 162 - 168
  • [40] Amyloid-beta and tau proteins as biochemical markers of Alzheimer's disease
    Sobów, T
    Flirski, M
    Liberski, PP
    ACTA NEUROBIOLOGIAE EXPERIMENTALIS, 2004, 64 (01) : 53 - 70
12345